Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Roden

Showing results (111-120 of 175) with videos related to

Pageof 18
Sort By:
Journal of Ovarian Research|August 9, 2017
Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinomaRosie T Jiang, Anna Yemelyanova, Deyin Xing, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2008
Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2Hannah H Alphs, Ratish Gambhira, Balasubramanyam Karanam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Human papillomavirus type-16 virus-like particles activate complementary defense responses in key dendritic cell subpopulationsRongcun Yang, Francisco Martinez Murillo, Ken-Yu Lin, et al.
Vaccine|December 20, 2008
Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunityBalasubramanyam Karanam, Ratish Gambhira, Shiwen Peng, et al.
Breast Cancer Research : BCR|November 15, 2018
Evaluation of osteopenia and osteoporosis in younger breast cancer survivors compared with cancer-free women: a prospective cohort studyCody Ramin, Betty J May, Richard B S Roden, et al.
Journal of Virology|October 12, 2007
A protective and broadly cross-neutralizing epitope of human papillomavirus L2Ratish Gambhira, Balasubramanyam Karanam, Subhashini Jagu, et al.
Oncotarget|September 23, 2016
RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cellsRuey-Shyang Soong, Ravi K Anchoori, Benjamin Yang, et al.
Journal of Virology|April 17, 2020
Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient MiceCarolina Scagnolari, Fabiana Cannella, Alessandra Pierangeli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2014
Small-molecule RA-9 inhibits proteasome-associated DUBs and ovarian cancer in vitro and in vivo via exacerbating unfolded protein responsesKathleen Coughlin, Ravi Anchoori, Yoshie Iizuka, et al.
Cancer Research|February 3, 2006
Application of Bayesian modeling of autologous antibody responses against ovarian tumor-associated antigens to cancer detectionAl Erkanli, Douglas D Taylor, Deyrick Dean, et al.
Pageof 18

Showing results (111-120 of 175) with videos related to

Sort By:
Pageof 18
Journal of Ovarian Research|August 9, 2017
Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinomaRosie T Jiang, Anna Yemelyanova, Deyin Xing, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2008
Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2Hannah H Alphs, Ratish Gambhira, Balasubramanyam Karanam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Human papillomavirus type-16 virus-like particles activate complementary defense responses in key dendritic cell subpopulationsRongcun Yang, Francisco Martinez Murillo, Ken-Yu Lin, et al.
Vaccine|December 20, 2008
Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunityBalasubramanyam Karanam, Ratish Gambhira, Shiwen Peng, et al.
Breast Cancer Research : BCR|November 15, 2018
Evaluation of osteopenia and osteoporosis in younger breast cancer survivors compared with cancer-free women: a prospective cohort studyCody Ramin, Betty J May, Richard B S Roden, et al.
Journal of Virology|October 12, 2007
A protective and broadly cross-neutralizing epitope of human papillomavirus L2Ratish Gambhira, Balasubramanyam Karanam, Subhashini Jagu, et al.
Oncotarget|September 23, 2016
RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cellsRuey-Shyang Soong, Ravi K Anchoori, Benjamin Yang, et al.
Journal of Virology|April 17, 2020
Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient MiceCarolina Scagnolari, Fabiana Cannella, Alessandra Pierangeli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2014
Small-molecule RA-9 inhibits proteasome-associated DUBs and ovarian cancer in vitro and in vivo via exacerbating unfolded protein responsesKathleen Coughlin, Ravi Anchoori, Yoshie Iizuka, et al.
Cancer Research|February 3, 2006
Application of Bayesian modeling of autologous antibody responses against ovarian tumor-associated antigens to cancer detectionAl Erkanli, Douglas D Taylor, Deyrick Dean, et al.
Pageof 18